Merus NV (MRUS US)

Analysis

Health Care • Netherlands

Merus N.V. operates as a clinical-stage immuno-oncology company. The Company focuses on developing bispecific antibody therapeutics. Merus develops and manufactures therapeutics to treat and cure cancer patients.

Refresh

Company Presentation • 31 Oct 2025 22:00

Corporate Presentation

Company Presentation • 02 Jun 2025 19:00

Corporate Presentation

Company Presentation • 16 Dec 2024 20:00

Corporate Presentation

Company Presentation • 23 May 2025 05:30

Status Update

Company Presentation • 07 Dec 2024 22:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate Presentation

Corporate Presentation

Corporate Presentation

Status Update

Investor Update